Q5122 Injection, nyvepria
Also known as: Nyvepria injection, pegfilgrastim-apgf
Injection of Nyvepria, pegfilgrastim-apgf biosimilar, a long-acting granulocyte-colony stimulating factor.
In Plain Language
chemotherapy support medication; white blood cell enhancer
Clinical Context
Used for chemotherapy-induced neutropenia prevention and bone marrow support.
RVU Information
CPT Q5122 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5122?
CPT Q5122 (Injection, nyvepria) is a Q Codes code. Injection of Nyvepria, pegfilgrastim-apgf biosimilar, a long-acting granulocyte-colony stimulating factor.
Is Q5122 covered by insurance?
Q5122 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for chemotherapy-induced neutropenia prevention and bone marrow support.
When is CPT Q5122 used?
Used for chemotherapy-induced neutropenia prevention and bone marrow support.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.